Prospective, Multicenter, Randomized Controlled, Phase III Clinical Study of Armatinib Alone or in Combination With Stereotactic Body Radiotherapy (SRT) for First-line Treatment of Brain Metastases From EGFR-mutated Non-small Cell Lung Cancer.

Aim: To investigate the timing, efficacy and safety of radiotherapy in patients with EGFR positive brain metastases treated with armatinib alone or combined with stereotactic radiotherapy. Keywords: Asia; Brain Diseases and Conditions; Brain Metastasis; Cancer; China; Clinical Research; Clinical Trials and Studies; Drug Administration Routes; Drugs and Therapies; Enzymes and Coenzymes; Genetics; Health and Medicine; Hospitals; Lung Cancer; Lung Diseases and Conditions; Lung Neoplasms; Non-Small Cell Lung Cancer; Oncology; Oncology - Non-Small Cell Lung Cancer; Oral Administration; Radiotherapy; Surgery; Transaminases EN Asia Brain Diseases and Conditions Brain Metastasis Cancer China Clinical Research Clinical Trials and Studies Drug Administration Routes Drugs and Therapies Enzymes and Coenzymes Genetics Health and Medicine Hospitals Lung Cancer Lung Diseases and Conditions Lung Neoplasms Non-Small Cell Lung Cancer Oncology Oncology - Non-Small Cell Lung Cancer Oral Administration Radiotherapy Surgery Transaminases 51 51 1 04/17/23 20230417 NES 230417 2023 APR 17 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Staff editors report on the newly launched clinical trial, NCT05800223, which has the following summary description: "Objective:Patients with asymptomatic or minimally symptomatic Stage IV EGFR-positive NSCLC with baseline intracranial metastases. [Extracted from the article]

Copyright of AIDS Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)